Fresenius Medical Care AG & Co. KGaA

NYSE:FMS

Medical - Care Facilities

Healthcare
$20.95 -0.76%

-$0.18 today

Market cap
$11.26B
Beta
0.81
P/E (TTM)
11.9
EPS (TTM)
$3.43
Dividend yield
3.65%
52W Low $20.02High $28.87

Volume 1.92M

Average 0.72M

FMS Tax Payables

Taxes owed to authorities that have not yet been paid.

Fresenius Medical Care AG & Co. KGaANYSE: FMS

Tax Payables · Q2 FY2026 · quarter ended Jun 2026

Tax payables rises 39.0% from a year ago

Tax payables stood at €232.85M at the end of Q2 FY2026, up 39.0% from a year earlier and up 53.4% from the prior quarter.

Context

  • Tax payables amounted to 0.7% of total assets at the end of Q2 FY2026, up 0.2 pp from a year earlier.
  • Tax payables increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether tax payables keeps rising in the next quarterly balance sheet after a +39.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
€232.85M+53.4% QoQ
Last fiscal yearDec 2025
€0-100.0% YoY
Year agoJun 2025
€167.56M+39.0% since
Tax Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+39.0%——
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Tax Payables history

EUR · from the balance sheet

Latest · FY2025
0 EUR
Year-over-year change
-100.0%

Tax Payables vs competitors

How FMS compares with its peers on the latest reported figures

  • Peers report in different currencies, so tax payables is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +39.0% is the highest of 2, against a peer median of +25.0%.
  • Tax payables amounts to 0.7% of total assets for FMS, versus a peer median of 0.0%.
FMS Competitors
Tax Payables for FMS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
FMSFresenius Medical Care AG & Co. KGaAJun 2026€232.85M EUR+39.0%—0.7%
DVADaVita Inc.Jun 2026$24.62M USD+25.0%—0.1%
TVTXTravere Therapeutics, Inc.Sep 2026$0 USD——0.0%
AKBAAkebia Therapeutics, Inc.Mar 2026$0 USD——0.0%
Peer median (excluding FMS) —+25.0%—0.0%

Competitors are the stored peer set for FMS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.48B1.27B1.4B1.18B1.6B
Short-term Investments159.18M187.83M154.37M163.09M0
Net Receivables3.58B3.72B3.64B3.41B3.14B
Inventory2.04B2.3B2.18B2.07B2.14B
Other Current Assets672.58M682.6M1.28B1.06B1.02B
Total Current Assets7.97B8.2B8.7B7.92B7.9B
Property, Plant & Equipment (Net)8.55B8.34B7.45B7.26B3.01B
Goodwill14.36B15.79B14.65B15.17B0
Intangible Assets1.46B1.52B1.36B1.37B14.83B
Long-term Investments786.91M1.2B1.08B1.12B0
Tax Assets00000
Other Non-current Assets1.24B702.46M681.83M720.02M5.26B
Total Non-current Assets26.4B27.55B25.23B25.64B23.1B
Total Assets34.37B35.75B33.93B33.57B31B
Account Payables857.53M951.58M885.15M984.32M738M
Short-term Debt1.92B1.34B944.6M577.38M1.61B
Tax Payables265.13M267.87M331.86M282.64M0
Deferred Revenue518.03M105.72M85.82M82.17M0
Other Current Liabilities2.75B2.86B2.99B2.84B3.31B
Total Current Liabilities7.26B6.47B6.11B5.66B6.25B
Long-term Debt6.65B7.17B6.96B6.26B5.69B
Deferred Tax Liabilities868.45M936.48M750.29M708.89M0
Deferred Revenue (Non-current)09.47M13.87M34.02M0
Other Non-current Liabilities1.53B1.72B1.74B1.63B1.88B
Total Non-current Liabilities13.13B13.84B12.99B12.14B10.47B
Total Liabilities20.39B20.3B19.1B17.8B16.72B
Common Stock293M293.41M293.41M293.41M14.28B
Retained Earnings10.83B10.71B10.92B11.27B0
Accumulated OCI(1.31B)(388.47M)(975.17M)(328.55M)0
Other Stockholders Equity00000
Minority Interest1.28B1.46B1.21B1.19B0
Total Equity13.98B15.45B14.83B15.77B14.28B
Total Debt13.32B13.21B12.08B11B10.8B
Net Debt11.84B11.94B10.67B9.82B9.2B

Fresenius Medical Care AG & Co. KGaA

NYSE:FMS

Intrinsic Alpha fair value

Locked

Current Price

$20.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.